People without memory problems could be diagnosed with Alzheimer's under a plan by an influential scientific panel dominated by members with ties to drug companies.| Los Angeles Times
The most influential researchers have long believed so dogmatically in one theory of Alzheimer’s that they thwarted alternative approaches.| STAT
Some people advocate giving Alzheimer's disease drugs to people with normal cognitive function who have elevated amyloid levels in their brains. This is not only wrong, but dangerous.| The Hastings Center
A poem about the Alzheimer's drug Aduhelm and Medicare's upcoming (April 11 2022) final coverage decision| ChangingAging
* A reflection on STAT article: Joseph, A. (June 16, 2021). Q&A: The CEO of the Alzheimer’s Association on the approval of Aduhelm – and why critics should stop dwelling on the decision. Link: https://www.statnews.com/2021/06/16/qa-ceo-alzheimers-association-on-aduhelm/ A lot has been said and written in recent weeks about the FDA controversial approval of the drug Aduhelm and the […]| ChangingAging